Core Viewpoint - Rosen Law Firm is encouraging investors of aTyr Pharma, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - Investors who purchased aTyr Pharma common stock between January 16, 2025, and September 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The lawsuit claims that aTyr Pharma provided misleading statements regarding the efficacy of its drug Efzofitimod, particularly concerning its ability to allow patients to taper steroid usage completely [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]. Group 3: Next Steps for Investors - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - It is noted that no class has been certified yet, and investors are not represented unless they retain counsel [8].

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit on behalf of investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period, highlighting potential misrepresentation regarding the market demand for the Inspire V sleep apnea device [2][6]. Group 1: Class Action Details - The class action lawsuit pertains to purchases made between August 6, 2024, and August 4, 2025, and aims to address alleged misleading statements made by the defendants regarding the demand and launch of the Inspire V device [2][6]. - Investors who purchased Inspire Medical common stock during the Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Process and Participation - Interested investors can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for January 5, 2026 [4][7]. - It is noted that no class has been certified yet, meaning investors are not represented by counsel unless they choose to retain one [8]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its success in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hormel Foods Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a Wall Street Journal article published on October 29, 2025, which reported that Hormel cut its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility [3]. - Following the news, Hormel Foods' stock experienced a significant decline of 9.1% on the same day [3]. Group 2: Class Action Information - Shareholders who purchased Hormel securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested investors can join the prospective class action by visiting the provided link or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Core Viewpoint - A new securities class action lawsuit has been filed against CarMax, Inc., expanding the class period to include investors who acquired securities between June 20, 2025, and November 5, 2025, following a significant drop in share price after the firing of CEO Bill Nash [1][2]. Group 1: Class Action Details - The expanded class period for the lawsuit is from June 20, 2025, to November 5, 2025, with a lead plaintiff deadline set for January 2, 2026 [2]. - The lawsuit focuses on allegations that CarMax misled investors regarding the strength of its business model and growth prospects [2][3]. Group 2: Financial Performance and Misleading Information - On June 20, 2025, CarMax reported double-digit EPS growth for Q1 2026, claiming a strong market position, which the lawsuit alleges was misleading [3]. - Investors learned of the company's actual performance on September 25, 2025, when CarMax reported a 24% year-over-year decline in net EPS, alongside a 5.4% drop in retail used unit sales and a 6.3% decline in comparable store used unit sales [4]. - Concerns were raised about the quality of CarMax's Auto Finance loan portfolio, which saw an 11.02% revenue decline year-over-year due to a $142 million loan loss provision, contradicting previous reassurances from management [5]. Group 3: CEO Termination and Market Reaction - The termination of CEO Bill Nash on November 6, 2025, led to a significant market reaction, with shares dropping by $9.48, or 23% [1][6]. - Analysts have expressed concerns that the situation reflects deeper issues within CarMax, shifting perceptions from a value play to a more precarious investment [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities between December 4, 2024, and September 9, 2025, of the December 30, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who acquired Synopsys securities during the specified Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is December 30, 2025, with the lead plaintiff representing other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Synopsys made materially false and misleading statements and failed to disclose adverse facts about its business and operations during the Class Period [5]. - Specific claims include the negative impact of Synopsys' focus on artificial intelligence customers on its Design IP business and the misleading nature of the company's positive statements regarding its prospects [5].

Core Viewpoint - Rosen Law Firm is urging investors of Baxter International Inc. to secure legal counsel before the December 15, 2025 deadline for a securities class action related to stock purchases made between February 23, 2022, and July 30, 2025 [2][3]. Group 1: Class Action Details - Investors who purchased Baxter common stock during the specified Class Period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [3]. - The lawsuit alleges that Baxter misled investors by failing to disclose systemic defects in the Novum IQ Large Volume Pump, which led to serious risks for patients, including malfunctions that could result in underinfusion, overinfusion, or non-delivery of fluids [6]. - Baxter was reportedly aware of multiple device malfunctions and injuries but did not take adequate remedial measures, leading to a heightened risk of product recalls and halting new sales [6]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [5]. - The Rosen Law Firm has a history of successful settlements in securities class actions, having recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [1] Group 1: Legal Actions and Stock Performance - Western Alliance Bancorporation initiated a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [3] Group 2: Class Action Information - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, with Rosen Law Firm preparing to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Firefly Aerospace Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Investigation Details - The investigation is prompted by a report indicating that Firefly Aerospace may have provided misleading information regarding its business performance [1]. - Shareholders who purchased Firefly Aerospace securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. Group 2: Financial Performance - On September 22, 2025, The Wall Street Journal reported that Firefly Aerospace posted a wider loss and lower revenue in its latest quarter, marking its first earnings report since its stock market debut [3]. - Following the publication of this report, Firefly's stock experienced a decline of 15.3% on September 23, 2025 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class actions [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period, highlighting potential misrepresentation regarding the market demand for its sleep apnea device, Inspire V [2][6]. Group 1: Class Action Details - The class action lawsuit pertains to purchases made between August 6, 2024, and August 4, 2025, and aims to address alleged misrepresentations by the company regarding the demand and launch of the Inspire V device [2][6]. - Investors who purchased Inspire Medical common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Process and Participation - Interested investors can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for January 5, 2026 [4][7]. - It is noted that no class has been certified yet, meaning investors are not represented by counsel unless they retain one [8]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in terms of securities class action settlements and has recovered hundreds of millions of dollars for investors over the years [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of Nidec Corporation shareholders due to allegations of materially misleading business information issued by the company [2][3]. Group 1: Investigation Details - The investigation is prompted by a significant drop in Nidec's stock price, which fell 22% following a report of accounting issues related to its management [4]. - Nidec's American Depositary Receipts (ADRs) experienced a decline of 22.7% on September 4, 2025, marking the largest one-day drop for the company [4]. Group 2: Class Action Information - Investors who purchased Nidec Corporation securities may be eligible for compensation through a class action lawsuit, with no upfront costs due to a contingency fee arrangement [3]. - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [5].